CoagulationDisorders near North Bergen, NJ

Biography: Dr. Stephanie Blank, MD is an Oncology Specialist who practices in New York, NY. She is 59 years old and has been practicing for 31 years. Dr. Stephanie Blank, MD is affiliated with Mount Sinai Morningside, Mount Sinai Brooklyn and Mount Sinai Queens.

Biography: Dr. Samantha Cohen, MD is an Oncology Specialist who practices in New York, NY. She is 53 years old and has been practicing for 21 years. Dr. Samantha Cohen, MD is affiliated with Mount Sinai Queens, Mount Sinai Morningside and Mount Sinai Brooklyn.

Biography: Paul Chapman, MD is currently the Chief Medical Research Officer for the Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Dr. Chapman received his M.D. degree from Weill Cornell Medical College in 1981 and trained in internal medicine as an intern and resident at the University of Chicago Hospitals and Clinics from 1981-1984. After that, he returned to New York as a medical oncology Fellow at Memorial Sloan Kettering Cancer where he focused on immunotherapy of melanoma in the laboratory of Dr. Alan Houghton. He joined the faculty of Memorial Sloan Kettering Cancer Center (MSKCC) in 1988 and worked there through 2023 as a tenured Attending Physician. During this time at MSKCC, Dr. Chapman led many clinical and laboratory studies designed to develop new and improved treatments for melanoma. This included the first BRAF targeted therapy trial and several immunotherapy trials. His research continues to focus on developing new treatments for melanoma.

Biography: Dr. Mateo Mejia is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital.Dr. Mejia received his medical degree (M.D.) from the Universidad CES in his hometown of Medellin, Colombia, after which he completed an internal medicine residency at the Jacobi Medical Center/Albert Einstein College of Medicine in the Bronx, NY, where he also served as a Chief Resident. He completed his Hematology and Oncology fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital and joined the Hematology and Medical Oncology Division after completing his fellowship training in 2023. During fellowship, Dr. Mejia developed his clinical experience under the mentorship of Dr. Ruben Niesvizky, while pursuing his laboratory research at Dr. Mark Bustoros' Laboratory, being able to complete both clinical and translational research in the plasma cell malignancy field.Dr. Mejia's research has focused on the genomic drivers of aggressive forms of myeloma, for which he received the 2022 Conquer Cancer American Society of Clinical Oncology (ASCO) Young Investigator Award, a prestigious honor only given to 100 of people each year. Additionally, Dr. Mejia was the recipient ofthe 2022 Charles, Lillian and Betty Neuwirth Foundation Fellowship in Oncology award for his project "Genomic Landscape of Multiple Myeloma with Extramedullary Disease". Dr. Mejia's research also investigates the connectionof race, ethnicity and myeloma, how myeloma escapes the surveillance of the immune system, as well as how genetic information can be used to develop novel approaches to treat myeloma.

Biography: Dr. Charles Shapiro, MD is a Hematology Specialist who practices in New York, NY. He is 68 years old and has been practicing for 41 years. Dr. Charles Shapiro, MD is affiliated with Mount Sinai Hospital.

Biography: Alana Nguyen, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology at Weill Cornell Medicine/NewYork-Presbyterian Hospital.Dr. Nguyen received her MD from Boston University in Boston, Massachusetts and herPhD from McGill University in Montreal, Canada. She went on to complete her postgraduate medical training in Internal Medicine at the Mount Sinai Hospital in New York City. After her residency, she entered fellowship training in Medical Oncology at Columbia University/New York-Presbyterian Hospital in the Physician-Scientist Pathway.Dr. Nguyen sees patients with malignancies of the digestive tract in her clinical practice.In addition, her research focuses on drug development based on biological understanding of therapy resistance. She received a Women Who Conquer Cancer Award from the American Society for Clinical Oncology and its Conquer Cancer Foundation for her work on a 3-dimensional culture model of patient tumors to predict for patients' response to chemotherapy and immunotherapy. Using this innovative model, her current research will focus on understanding the tumor microenvironment of pancreatic cancer, and how this tumor microenvironment participates in drug evasion.

Care Philosophy: My philosophy is simple: the patient comes first. As part of the Genitourinary Oncology Program at Weill Cornell Medicine, I am committed to delivering the best care to my patients. Our world-class multidisciplinary team ensures that we treat the patient as a whole, not just the cancer. I am driven by the desire to improve therapy of urological malignancies by identifying the genetic "Achilles heel" of each patient's cancer. Through my research, I am committed to developing "precision medicine" approaches and conducting clinical trials for treatment of bladder cancer and other genitourinary malignancies.